Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry
Authors:
- Daniel BarthelmesDBDaniel Barthelmes
- Richard BarryRBRichard Barry
- Louise O’TOoleLOLouise O’TOole
- Theodorus Leonardus PonsioenTPTheodorus Leonardus Ponsioen
- Helena Brosa MorrosHMHelena Brosa Morros
- Catherine Creuzot-GarcherCCCatherine Creuzot-Garcher
- Mark GilliesMGMark Gillies
- Pierre-Henry GabriellePierre-Henry Gabrielle
Open Access
- 20 April 2026
- journal article
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (8) , 833-843
Abstract
No abstract availableKeywords
Funding Information
- Macular Disease Foundation Australia
- Bayer
- Novartis
This publication has 26 references indexed in Scilit:
- Features Associated With Vision in Eyes With Subfoveal Fibrosis From Neovascular Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2023
- Loss to Follow-up in Patients with Neovascular Age-Related Macular Degeneration Treated with Anti–VEGF Therapy in the United States in the IRIS® RegistryOphthalmology, 2023
- Defining Nonadherence and Nonpersistence to Anti–Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular DegenerationJAMA Ophthalmology, 2021
- Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular DegenerationOphthalmology, 2021
- Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsAmerican Journal of Ophthalmology, 2020
- Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World StudiesAdvances in Therapy, 2019
- Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti–Vascular Endothelial Growth Factor InjectionsJAMA Ophthalmology, 2018
- Segmented generalized mixed effect models to evaluate health outcomesInternational Journal of Public Health, 2018
- Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular DegenerationOphthalmology, 2015
- Pathophysiology of age-related macular degenerationSurvey of Ophthalmology, 1987